This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.
At a glance
Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.
An open check means the public sources were not specific enough—not that the service failed the check.
Resumen en español
Form Health para usuarios hispanohablantes
Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.
No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.
- si la cita concreta será en español;
- el coste mensual ordinario y qué incluye;
- la licencia estatal del profesional;
- el medicamento, la farmacia y el coste por separado.
Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.
Comparar proveedores para hispanohablantes en EE. UU. →How the program is structured
A physician-led obesity and cardiometabolic clinic with monthly clinician and dietitian video visits, insurance billing, labs, FDA-approved medications, unlimited messaging, and a $299 self-pay clinical option. It does not prescribe compounded GLP-1s.
GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.
Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.
Service configuration
These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.
- Provider type
- Telehealth program
- Medicine context
- Semaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes) · Liraglutide (Saxenda; Victoza for type 2 diabetes)
- Formats reviewed
- Injection · Oral medicine
- Funding routes
- Insurance support · Private pay
- Service features
- Coaching · Clinician support · Switching pathway · Home delivery
- Access check
- Confirm current state access
- Evidence status
- Primary sources reviewed
- Research depth
- 3 cited sources · 3 medicine rows · 4 open checks
Recurring cost breakdown
- In-network visits, lab tests, and medications are billed to insurance with patient copay/deductible.
- $299/month self-pay covers clinician visits, dietitian appointments, unlimited messaging, and platform access.
- Self-pay patients remain responsible for labs and medication.
- No separate medication bundle is promised.
- Medicine + dose
- Membership or consultation
- Delivery + supplies
- Labs + follow-up
- Renewal after offers
Medication and formulation matrix
| Medication | Form | Regulatory / program path | Published price view |
|---|---|---|---|
| Wegovy / Zepbound / Foundayo / Saxenda / Contrave | Oral or injectable | FDA-approved weight-management options | Insurance/copay or pharmacy cash price |
| Metformin / bupropion / naltrexone / topiramate / zonisamide | Oral | FDA-approved drugs; weight use may be off-label | Insurance or pharmacy cash price |
| Ozempic / Rybelsus | Injection / oral | FDA-approved for type 2 diabetes | Indication and coverage dependent |
Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.
State-by-state availability
- Virtual access is offered in supported states through licensed clinicians.
- A full public all-state guarantee is not made on the reviewed program pages; verify enrollment using the patient’s location.
Clinician access and follow-up cadence
- Monthly video visits with both a Form clinician and Registered Dietitian are published.
- Unlimited care-team messaging is included.
- Initial visits include medical-record review and coordination with an existing primary-care physician.
Pharmacy and fulfillment
- Prescriptions use covered or patient-selected pharmacy channels; medication is not bundled.
- The care team can help choose covered options, but a universal named pharmacy is not used.
Insurance and prior authorization
- Form accepts most major private insurance and Medicare.
- The team reviews coverage, submits prior authorizations, and advocates after denials.
- The actual copay/deductible remains the patient’s responsibility.
Cancellation, refund, and commitment
- Membership can be canceled at any time.
- The care team offers a transition plan; ordinary visit, lab, and pharmacy obligations already incurred remain separate.
Labs, monitoring, and dose management
- Labs are billed through insurance for insured patients and separate for self-pay patients.
- Regular medical monitoring is required for ongoing prescribing.
- Enrollment requires an existing PCP visit within the prior 12 months and medical-record sharing.
Maintenance and switching
- The program is designed for sustained, coordinated care and can develop an exit transition plan.
- A transfer requires medical records and PCP coordination, making it more comprehensive but potentially slower than a medication-only service.
Program snapshot
Specialist obesity care
Profiled support: Ongoing clinician access, Coaching or behavior support.
Insurance help · Cash pay
Form advertises insurance and employer relationships; eligibility and network status must be confirmed.
Verify before purchase
Prescriptions typically follow normal pharmacy benefit and dispensing channels.
What the advertised program may include
- Obesity-medicine physician care
- Registered dietitian support
- Longitudinal follow-up
- Medication management when appropriate
Useful comparison signals
Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.
- Starting care and comparing first-provider requirements
- Switching providers or continuing an established treatment
- Ongoing clinician access
- Coaching or behavior support
Open evidence gaps
These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.
- Public state-by-state enrollment table
- Guaranteed authorization turnaround
- Medication net cost before benefit review
- Pharmacy choice before prescribing
Questions to ask before paying
- What is the ordinary recurring total after any introductory period?
- Does that total include clinician care, medication, supplies, labs, and shipping?
- Which clinician group and dispensing pharmacy will be responsible for my care?
- What happens to billing if I am not prescribed the advertised treatment?
- What records and timing do you require if I am switching from another provider?
Source ledger
Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.
Monthly cadence, self-pay price, insurance, cancellation and care model
Current medication matrix and no-controlled-substance scope
Eligibility, insurance, labs, monitoring and cancellation